Bionano Genomics, Inc.
Bionano Genomics, Inc.（BNGO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
bngo · 股价预测 · 7 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 7 位华尔街分析师
Buy
7 位分析师
共识
评级分布
12 个月目标价
High
$175
Consensus
$46.50
+3874.0% upside
Low
$1.00
Median: $5 · Last Close: $1.17
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.17 | ↑ 0.30% |
1-day model range: $1.16–$1.19. Peak: $1.19 (+0.30%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · BNGO · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-20 | Maxim Group | Upgrade ↑ | Hold→Buy |
| 2025-04-02 | Scotiabank | Maintains | Sector Perform→Sector Perform |
| 2024-11-15 | Ladenburg Thalmann | Downgrade ↓ | Buy→Neutral |
| 2024-05-16 | BTIG | Maintains | Buy→Buy |
| 2024-03-07 | Scotiabank | Maintains | Sector Outperform→Sector Outperform |
| 2023-11-13 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2023-08-10 | BTIG | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Bionano Genomics, Inc. (BNGO) stock. Of the recent 18 rating actions, 1 were upgrades and 3 were downgrades. 7 analysts currently cover BNGO.
分析师推荐趋势
BNGO analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$32M
↓ 41.4% YoY
Revenue Next Year
$43M
↑ 34.7% YoY
EPS This Year
$-2.31
EPS Next Year
$-0.97
↓ 58.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast BNGO EPS of $-2.31 for the current fiscal year, based on estimates from 1 analysts. The BNGO revenue forecast is $32M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
BNGO 股价预测由两类独立数据源支撑：来自 7 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。BNGO 的共识目标价为 $46.50（+3874.0% 上行空间），分析师共识为 Buy。
BNGO 的短期预测（明日）为 $1.17（+0.30%）。 BNGO 对 2030 年的预测区间为 $0–$0。
Bionano Genomics, Inc. 在 NASDAQ 上市，代码 BNGO。BNGO 在 2027 年的整体展望偏积极，在覆盖分析师中约 57% 对应 Buy 共识。
常见问题
BNGO 预测 · 8 个问题根据 7 位华尔街分析师，BNGO 的 12 个月平均目标价为 $46.50，最高 $175.00、最低 $1.00。若有图表，中位目标价可在上方查看。相对当前价 $1.17，隐含约 +3874.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.